Stratton Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
JSP
Stratton Management's NVO Position: Q4 2015 in Review
Stratton Management reduced its Novo Nordisk (NVO) stake by 0.54% in Q4 2015, selling an estimated $55.4K and leaving 370,000 shares worth $10.7M. The position accounts for 1.3% of the portfolio, ranked #16.
Stratton Management first reported a position in NVO in Q2 2013 and has held it in 11 quarters since. The position peaked at $11.9M in Q1 2014. 549 funds tracked by Wall St. Rank hold NVO as of Q4 2015.
- Stratton Management held 370,000 shares of Novo Nordisk worth $10.7M as of Q4 2015.
- Stratton Management sold 2,000 Novo Nordisk shares in Q4 2015, an estimated $55.4K.
- Novo Nordisk made up 1.3% of Stratton Management's portfolio in Q4 2015, its #16 holding.
- Stratton Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 11 quarters since.
- Stratton Management's Novo Nordisk position peaked at $11.9M in Q1 2014.
- 549 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2015.
Based on Stratton Management's 13F filing for Q4 2015, filed 11 Feb 2016.